Patent · US Active

Process for the synthesis and crystalline form of agomelatine

US7498466B2 · kind B2 · utility

2Cited by
3References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2007
Grant dateMar 3, 2009
Priority date
Expiry dateMay 31, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the industrial synthesis and new crystalline form of the compound of formula (I):Medicinal products containing the same which are useful in treating disorders of the melatoninergic system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.